To validate the quantitative MS and analysis, western blot analysis to assess p53 and AURKB protein levels was performed on whole cell lysates collected from a small panel of CRC cell lines treated with 5-FU over 48 h. The gene discussed is TP53; the disease is colorectal carcinoma.